Search

everythinglearnresearchcommunity

for

Search:↓

The diagnosis of polycystic ovary syndrome (PCOS) requires a detailed patient history, ultrasound scanning, hormone level checks, and assessments of ovulation, obesity, and insulin resistance. It's a variable condition that needs individualized management and is a significant risk factor for type 2 diabetes.

Blood tests are needed to confirm high male hormone levels in women with PCOS, as physical signs alone are not reliable.

Metabolic syndrome is linked to skin diseases, requiring integrated treatment and monitoring.

ADSC-derived extracellular vesicles show promise for skin and hair regeneration and wound healing.

Different immune cells like platelets, mast cells, neutrophils, macrophages, T cells, B cells, and innate lymphoid cells all play roles in skin wound healing, but more research is needed due to inconsistent results and the complex nature of the immune response.

Blood tests can detect ovarian Leydig cell tumors when scans don't, and surgery can confirm and treat these tumors.

Melatonin may help treat various diseases and is influenced by magnetic fields, but more research is needed.

Curcumin improved some metabolic factors in women with PCOS but did not affect cholesterol, insulin, or testosterone levels.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.

Women with Polycystic Ovary Syndrome have a higher chance of getting depressed.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Eating a high inositol diet significantly improves insulin resistance and hormone levels in women with PCOS.

Hair follicles supply a crucial brain development protein to the brain via platelets.

People with common hair loss conditions may have a higher risk of heart disease and related health issues.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

Cell-based therapy using specific immune cells may help treat alopecia areata by promoting hair regrowth.

Eating barley for life may lead to healthier aging in mice.

Metformin is less effective in men with early-onset hair loss.

The new rodent model successfully mimics non-lean human PCOS symptoms.

Mesenchymal stem cell proteins in a special gel improved healing of severe burns.

Classical PCOS types A and B are most common and linked to higher health risks.

Thrombophilic conditions may worsen Long COVID symptoms due to increased blood clotting.

Radiation therapy damages skin structure and immune function, causing inflammation and potential hair loss.

Stem cell therapy shows promise for hair loss treatment, but more research is needed to confirm its effectiveness.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

A blood pressure drug, diltiazem, may also help treat influenza.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

The Polish medical societies have redefined metabolic syndrome and recommend lifestyle changes, certain medications, and possibly bariatric surgery for treatment. They also discuss managing related health conditions.